Skip to main content

BMT Symposium

The Advances in Blood and Marrow Transplantation (BMT) Symposium is an annual conference sponsored by The University of Kansas Cancer Center Blood and Marrow Transplant Program, National Marrow Donor Program "Be the Match", and the University of Kansas Medical Center's Area Health Education Center. The conference offers a review of the latest advances in the field of autologous and allogeneic transplantation including, current state-of-the-art treatment strategies, clinical trials research and outcomes of both autologous and allogeneic (related and unrelated donor) transplants to aid in your clinical decision making.

The Advances in Blood and Marrow Transplantation 2019 Symposium 
Saturday, April 13, 2019

Registration is closed at this time. Onsite registrations will be accepted as space permits.

2019 Featured Speakers

Nationally renowned guest speakers

 

David Miklos, M.D., Ph.D.

Associate Professor of Medicine; Clinical Director, Cancer Cell Therapy Program, Division of Blood and Marrow Transplantation, Stanford University

Bipin N. Savani, M.D.

Professor of Medicine; Director, Long-Term Transplant Clinic, Vanderbilt University Medical Center

Dr. Savani's area of specialization is in the treatment of hematological malignancies and stem cell transplantation, and his primary field of research is in the long-term follow-up after transplantation, including regimen-related toxicity/supportive care, and outcomes analysis of transplant recipients. Dr. Savani has published over 350 peer-reviewed articles, reviews, book chapters, editorials, perspectives and commentaries in the field of hematological malignancies and stem cell transplantation. He is an associate editor of the journals British Journal of Haematology, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation; and serves as an editorial advisory board member for several journals in the field. Dr. Savani serves as director of community/ clinical practice and board member of the American Society of Blood and Marrow Transplantation (ASBMT) and Foundation for the Accreditation of Cellular Therapy (FACT). Dr. Savani is currently Co-Chair of the Steering Committee on Practice Guidelines (ASBMT) and the leader of the Conditioning Regimen Subcommittee of the Acute Leukemia Working Party of the EBMT. He also serves as Clinical Trials Advisory Committee member-CIBMTR and medical monitor for Blood and Marrow Transplant Clinical Trial Network (BMT-CTN). Dr. Savani is a member of the ASH Committee on Practice (COP) and a liaison member from the COP to the ASH Task Force on Immunotherapies and Continuing Medical Education (CME) accreditation subcommittee. In 2013-2018, Dr. Savani served as Co-Chair of the late effects and quality of life working party, CIBMTR. He has recently edited several special issues for Seminars in Hematology, Hematology/ Oncology Clinics of North America and edited Wiley books entitled "Blood and Marrow Transplantation Long Term Management: Prevention and Complications" and "Clinical guide to transplantation in lymphomas".

Rachel B. Salit, M.D.

Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center

Krishna Komanduri, M.D.

Professor of Medicine; Director, Adult Stem Cell Transplant Program, University of Miami, Sylvester Cancer Center

Dr. Komanduri holds the Kalish Family Chair in Stem Cell Transplantation and is Professor of Medicine, Microbiology & Immunology and is the Director of the Adult Stem Cell Transplant Program and Associate Director for Clinical Innovation at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. He has been appointed inaugural Chair of the newly created Division of Transplantation and Cellular Therapy.

Dr. Komanduri received his undergraduate education at MIT (1987), his MD at the University of Minnesota Medical School (1991) and trained at UCLA (in Internal Medicine) and UCSF (in Hematology/Oncology). Prior to moving to Miami in 2008, he was a faculty member at UCSF and at the University of Texas M.D. Anderson Cancer Center. His laboratory research is focused on studies of cancer immunology and has been widely published and supported by the NIH and cancer-related foundations.

Dr. Komanduri served as the 2017-18 President of the American Society for Transplantation and Cellular Therapy (formerly the ASBMT). He serves as Co-Chair of the CIBMTR Working Committee on Infections and Immune Reconstitution and as a member of the Board of Directors of the National Marrow Donor Program (BeTheMatch) and as a member of the MIT NEWDIGS "think and do" tank on the financing of novel curative therapies in oncology. He has also served as Chair of the Immunology and Host Defense Scientific Committee for the American Society of Hematology and as a clinical expert for the Institute for Clinical and Economic Review Policy Roundtable on CAR-T Therapies. Dr. Komanduri co-chaired the 2018 ASBMT consensus conference on grading and reporting of toxicities for CAR-T cell therapies and continues to serve as co-chair of the ASBMT Committee on Cellular Therapies. He has been the recipient of awards including election to the American Society for Clinical Investigation (in 2009).

 

The University of Kansas Medical Center, School of Medicine Speakers

Siddhartha Ganguly, M.D.

Director, Lymphoma and Myeloma, Blood and Marrow Transplantation; Professor of Medicine

Dr. Ganguly developed an interest in stem cell transplantation as a way to cure clonal disorders at a very early stage in my training. After a year of fellowship training in BMT from the Cell and Gene Therapy Program at Baylor College of Medicine, Houston, TX, he joined as a faculty at the University of Kansas Medical Center in 2003. In addition to the clinical and educational responsibilities, he has been intimately involved with KU Medical Center Lymphoma and Myeloma Division's mission of research and development of new frontiers in cancer treatment. He has developed several investigator-initiated trials and take part in co-operative group sponsored projects. He has more than 15 years of experience in conducting clinical trials in a capacity as PI (both intramural and extramural funded projects, investigator-initiated and pharma-sponsored.) He is a member of the CIBMTR, Intergroup Myeloma Working Committee and worked closely with ASBMT to develop practice guidelines for transplantation in Myeloma published in BBMT in July 2015. He also holds a KU Cancer Center Funded IIT grant looking at in vivo purging for stem cell products in patients with myeloma undergoing apheresis. Recently he took part in an NCI sponsored Think Tank program to discuss Disparities in Myeloma care in the USA. 

Joseph McGuirk, DO

Chair, Medical Director, Blood and Marrow Transplantation, Professor of Medicine, Acute Leukemia

Dr. McGuirk is the Medical Director of the Blood and Marrow Transplant Program and the University of Kansas Medical Center. Additionally, he is the Director of the Division of Hematologic Malignancies and Cellular Therapeutics and a Schuette-Speas Professor of Hematology-Oncology at KU Medical Center. Dr. McGuirk earned his DO from the Kansas City University of Medicine and Biosciences in Kansas City Missouri. Since joining KU Medical Center, Dr. McGuirk has been involved in many different clinical and research interests, such as Blood and Marrow Transplantation, Allogeneic Stem Cell Transplantation, Hematological Malignancies, Autoimmune Diseases, and more. Dr. McGuirk has been named one of Ingram's Top Doctors as well as one of Kansas City Magazine's Super Doctors. He is also an Honorary Editorial Board Member of "Blood and Lymphatic Cancer: Targets and Therapy".

Tara Lin, M.D., MSCR

Associate Professor; Director, Acute Leukemia Program Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center

Tara Lin, MD, MSCR, is an Associate Professor in the Division of Hematologic Malignancies & Cellular Therapeutics at the University of Kansas, Kansas City, KS. She is the director of the Acute Leukemia Program and Medical Director of the KU Cancer Center Clinical Trials Office.

Dr. Lin received her medical degree from the Medical College of Virginia/Virginia Commonwealth University and a master's degree in clinical research from Tulane University. She completed a residency in Internal Medicine at the University of Maryland and a fellowship in Medical Oncology at Johns Hopkins. She completed an additional two-year post-doctoral fellowship in leukemia stem cells in the laboratory of Dr. Kathleen Sakamoto at UCLA.

Since 2011, she has been on the faculty at the University of Kansas, with a focus on novel therapeutics in acute leukemia.

 

Additional Presenters

Elizabeth Muenkis, Ph.D.

Assistant Professor, Onco-Psychology Service, Department of Psychiatry and Behavioral Sciences, The University of Kansas Medical Center

Elizabeth "Liz" Muenks, Ph.D. is an Assistant Professor of Psychology at the University of Kansas Medical Center, in the Department of Psychiatry and Behavioral Sciences. She is a licensed psychologist in the state of Kansas. Dr. Muenks' clinical work is specialized in cancer and she is a faculty member with the Onco-Psychology Program at the NCI-Designated University of Kansas Cancer Center. She earned her doctoral degree in Clinical Psychology from Saint Louis University. Dr. Muenks has research and clinical experience in diversity-related topics, minority psychology issues, and multiculturally competent practice, specifically as it pertains to cancer care. She co-chairs the Department of Psychiatry's Diversity Committee and also serves on the KU Medical Center's Diversity and Inclusion Cabinet. Currently, Dr. Muenks provides clinical services to cancer patients and their caregivers, with expertise in the presenting concerns and challenges of patients seen in the KU Cancer Center Blood and Marrow Transplant and Cellular Therapy Clinic.

Crissy Morrison, RN, BSN

Organ Transplant Nurse Coordinator, Bone Marrow Transplant Unit, The University of Kansas Medical Center

Last modified: Apr 11, 2019
ID=x26406